skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
 [1];  [1]
  1. The Scripps Research Inst., La Jolla, CA (United States)

The broad-spectrum antiviral drug Arbidol shows efficacy against influenza viruses by targeting the hemagglutinin (HA) fusion machinery. However, the structural basis of the mechanism underlying fusion inhibition by Arbidol has remained obscure, thereby hindering its further development as a specific and optimized influenza therapeutic. We determined crystal structures of Arbidol in complex with influenza virus HA from pandemic 1968 H3N2 and recent 2013 H7N9 viruses. Arbidol binds in a hydrophobic cavity in the HA trimer stem at the interface between two protomers. This cavity is distal to the conserved epitope targeted by broadly neutralizing stem antibodies and is ~16 Å from the fusion peptide. Arbidol primarily makes hydrophobic interactions with the binding site but also induces some conformational rearrangements to form a network of inter- and intraprotomer salt bridges. By functioning as molecular glue, Arbidol stabilizes the prefusion conformation of HA that inhibits the large conformational rearrangements associated with membrane fusion in the low pH of the endosome. Here, this unique binding mode compared with the small-molecule inhibitors of other class I fusion proteins enhances our understanding of how small molecules can function as fusion inhibitors and guides the development of broad-spectrum therapeutics against influenza virus.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); USDOE Office of Science (SC), Biological and Environmental Research (BER); National Cancer Inst.; National Inst. of General Medical Science (NIGMS); National Institutes of Health (NIH)
Grant/Contract Number:
AC02-76SF00515; AC02-06CH11357; Y1-CO-1020; Y1-GM-1104; P41GM103393; R56 AI117675
OSTI ID:
1343136
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Issue 2; ISSN 0027-8424
Publisher:
National Academy of SciencesCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 230 works
Citation information provided by
Web of Science

References (44)

The epidemiology and clinical impact of pandemic influenza journal May 2003
Design of inhibitors of influenza virus membrane fusion: Synthesis, structure–activity relationship and in vitro antiviral activity of a novel indole series journal August 2013
Aromatic rings act as hydrogen bond acceptors journal June 1988
Toremifene interacts with and destabilizes the Ebola virus glycoprotein journal June 2016
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin journal June 2000
Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories journal October 2014
Dual Resistance to Adamantanes and Oseltamivir Among Seasonal Influenza A(H1N1) Viruses: 2008–2010 journal January 2011
Exploring the gas access routes in a [NiFeSe] hydrogenase using crystals pressurized with krypton and oxygen journal August 2020
The contents of the syringe journal July 2008
Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection journal June 2013
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro journal May 2020
Preferential Recognition of Avian-Like Receptors in Human Influenza A H7N9 Viruses journal December 2013
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses journal January 2016
PHENIX : building new software for automated crystallographic structure determination journal October 2002
Influenza Activity — United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine journal June 2016
Current and future antiviral therapy of severe seasonal and avian influenza journal April 2008
Antiviral agents active against influenza A viruses journal December 2006
Antibody Recognition of a Highly Conserved Influenza Virus Epitope journal April 2009
Molecular mechanism of respiratory syncytial virus fusion inhibitors journal December 2015
Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity. journal January 1997
CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues journal July 2006
CH−π “T-Shape” Interaction with Histidine Explains Binding of Aromatic Galactosides to Pseudomonas aeruginosa Lectin LecA journal June 2013
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
Arbidol as a broad-spectrum antiviral: An update journal July 2014
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion journal November 2008
Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion journal April 2008
Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions journal October 2011
Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo journal May 2007
Influenza Vaccines: Challenges and Solutions journal March 2015
Structure of the Uncleaved Human H1 Hemagglutinin from the Extinct 1918 Influenza Virus journal March 2004
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution journal January 1981
Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010–2011 influenza season in Russia journal February 2016
Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol journal February 2009
NMRPipe: A multidimensional spectral processing system based on UNIX pipes journal November 1995
Global Transmission of Oseltamivir-Resistant Influenza journal March 2009
Cross-neutralization of influenza A viruses mediated by a single antibody loop journal September 2012
Highly Conserved Protective Epitopes on Influenza B Viruses journal August 2012
Automated analysis of interatomic contacts in proteins journal April 1999
Inhibition of influenza hemagglutinin with the antiviral inhibitor arbidol using a proteomics based approach and mass spectrometry journal November 2013
Multi-functionality of a tryptophan residue conserved in substrate-binding groove of GH19 chitinases journal January 2021
Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States journal February 2006
Phaser crystallographic software journal July 2007
Inhibitors of the early stages of virus-cell interactions among derivatives of 3-ethoxycarbonyl-5-hydroxy-6-bromoindole journal September 1992
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997

Cited By (21)

The broad-spectrum antiviral drug arbidol inhibits foot-and-mouth disease virus genome replication journal September 2019
Structural insights into the design of novel anti-influenza therapies journal February 2018
Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview journal September 2018
Potent peptidic fusion inhibitors of influenza virus journal September 2017
CASTp 3.0: computed atlas of surface topography of proteins journal June 2018
New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways journal July 2019
Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study: LENEVA et al. journal December 2018
Inhibition effects of patchouli alcohol against influenza a virus through targeting cellular PI3K/Akt and ERK/MAPK signaling pathways journal December 2019
Influenza Virus with Increased pH of Hemagglutinin Activation Has Improved Replication in Cell Culture but at the Cost of Infectivity in Human Airway Epithelium journal June 2019
Protein profiling and pseudo-parallel reaction monitoring to monitor a fusion-associated conformational change in hemagglutinin journal June 2019
A small-molecule fusion inhibitor of influenza virus is orally active in mice journal March 2019
An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus journal February 2020
A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo journal January 2020
ARVI antiviral therapy in children in modern clinical practice journal February 2019
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses journal January 2019
A Computationally Optimized Broadly Reactive Antigen Subtype–Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin journal December 2019
Structures of the prefusion form of measles virus fusion protein in complex with inhibitors journal February 2018
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases journal March 2020
A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin journal April 2018
Inhibition of H1N1 influenza virus-induced apoptosis by selenium nanoparticles functionalized with arbidol through ROS-mediated signaling pathways journal January 2019
Mutations in the Fusion Protein of Measles Virus That Confer Resistance to the Membrane Fusion Inhibitors Carbobenzoxy-d-Phe-l-Phe-Gly and 4-Nitro-2-Phenylacetyl Amino-Benzamide journal September 2017